Correlation Between Arbutus Biopharma and AC Immune

Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arbutus Biopharma Corp and AC Immune, you can compare the effects of market volatilities on Arbutus Biopharma and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and AC Immune.

Diversification Opportunities for Arbutus Biopharma and AC Immune

-0.45

Correlation Coefficient

Arbutus Biopharma  AC Immune

Very good diversification

The 3 months correlation between Arbutus and ACIU is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and AC Immune go up and down completely randomly.

Pair Corralation between Arbutus Biopharma and AC Immune

Given the investment horizon of 90 days Arbutus Biopharma Corp is expected to generate 1.18 times more return on investment than AC Immune. However, Arbutus Biopharma is 1.18 times more volatile than AC Immune. It trades about 0.2 of its potential returns per unit of risk. AC Immune is currently generating about -0.44 per unit of risk. If you would invest  254.00  in Arbutus Biopharma Corp on January 17, 2024 and sell it today you would earn a total of  43.00  from holding Arbutus Biopharma Corp or generate 16.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Arbutus Biopharma Corp  vs.  AC Immune

Arbutus Biopharma Corp

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Arbutus Biopharma Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Arbutus Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

AC Immune

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AC Immune has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Arbutus Biopharma and AC Immune

The main advantage of trading using opposite Arbutus Biopharma and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.

The idea behind Arbutus Biopharma Corp and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.